Covaxin, a candidate for BHARAT BIOTECH’s indigenous Covid vaccine currently in late-stage clinical trials, triggered humoral and cell-mediated immune responses and was well tolerated with no serious adverse events in its phase 2 trials, according to an article by Research released by the Hyderabad-based company, which has yet to be …
Read More »Covid-19: When, where and how to receive the vaccine? All you need to know
The Union Ministry of Health and Family Welfare has answered many of the public inquiries in the form of Frequently Asked Questions (FAQ) in its recently published document. The health ministry reiterated that vaccination against the coronavirus disease (Covid-19) is voluntary, however, it recommended that people receive the full dose …
Read More »Haryana Health Min Anil Vij, who has COVID-19, in critical condition
The minister is admitted to the Medanta Hospital of Gurugram. Haryana Health Minister Anil Vij, who is currently battling the COVID-19 infection, was admitted to Gurugram’s Medanta Hospital on Tuesday in critical condition, authorities said. The minister is undergoing treatment with Dr. Sushila Kataria, senior director of Medanta’s Department of …
Read More »Panel seeks more data on vaccines ahead of emergency approval
Written by Kaunain Sheriff M, Prabha Raghavan | New Delhi | Updated: December 10, 2020 7:08:31 am Pfizer, which received emergency clearance for the use of its Covid-19 vaccine in the UK, with the first doses delivered on Tuesday, had approached DCGI with a request that no clinical trials be …
Read More »Key meeting at DCGI on Pfizer, Serum and Covaxin vaccines; 64 diplomats visit Bharat Biotech
A committee of experts from the Central Standard Medicines Control Organization (CDSCO) will meet on Wednesday at 12 pm to review applications from Pfizer, Serum Institute of India and Bharat Biotech seeking emergency use authorization for their vaccine candidates. COVID-19, the sources said. The decision was made late Monday night …
Read More »With data from the UK and India, Covishield and Covaxin go to the regulator
Written by Prabha Raghavan, Anuradha Mascarenhas | New Delhi, Pune | Updated: December 8, 2020 7:15:08 am Hyderabad-based Bharat Biotech has included interim data from early and mid-stage human trials of its Covaxin vaccine candidate. (Archive) In its application for emergency use approval, Hyderabad-based Bharat Biotech has included interim data …
Read More »The government plans to vaccinate 30 CR people by July-August, says Vardhan
Union Health Minister Harsh Vardhan said on Monday that the central government plans to vaccinate between 25 and 30 million people against the new coronavirus by July-August next year. “In the first 3-4 months of next year, there is a possibility that we can provide vaccines to the people of …
Read More »Covid-19 Vaccine Covaxin Phase 3 Trial: No Adverse Effects After First Dose, Says Gujarat Hospital Official
Five volunteers have signed up for the phase 3 trials of Covaxin and were vaccinated with the first dose on Thursday. (File photo) Covaxin Coronavirus Vaccine Update: Volunteers given a dose of Covaxin vaccine have yet to complain of any health problems or symptoms, said a Gujarat-based hospital official, who …
Read More »PM asks CMs to prepare cold storage facilities, establish working group at district or block level
After two months, Prime Minister Narendra Modi on Tuesday held a virtual conference with senior ministers from all states and territories in the union to review the status and preparedness of the COVID-19 response and management, with special emphasis on eight states of high focus. These states were Haryana, Delhi, …
Read More »Covaxin from Bharat Biotech: volunteer hospitalized during early vaccine trials; This is what the company said
Covaxin is conducting Phase III vaccine trials in India (File photo) India is eagerly awaiting Covaxin, the locally made Covid-19 vaccine, which began its third phase trials in Odisha. As the Center prepares for a mega campaign, the vaccine manufacturer recently informed India’s Controller General of Drugs about a participant …
Read More »